Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 116

Similar articles for PubMed (Select 24016642)

1.

Toxic epidermal necrolysis: the experience of Coimbra's burn unit.

Pinheiro S, Carvalho R, Ramos S, Diogo C, Caetano M, Cabral L, Cruzeiro C.

Acta Med Port. 2013 Jul-Aug;26(4):341-8. Epub 2013 Aug 30.

2.

27 years of a single burn centre experience with Stevens-Johnson syndrome and toxic epidermal necrolysis: analysis of mortality risk for causative agents.

Weinand C, Xu W, Perbix W, Lefering R, Maegele M, Rathert M, Spilker G.

Burns. 2013 Nov;39(7):1449-55. doi: 10.1016/j.burns.2013.03.011. Epub 2013 May 20.

PMID:
23702222
3.

Antishear therapy for toxic epidermal necrolysis: an alternative treatment approach.

Dorafshar AH, Dickie SR, Cohn AB, Aycock JK, O'Connor A, Tung A, Gottlieb LJ.

Plast Reconstr Surg. 2008 Jul;122(1):154-60. doi: 10.1097/PRS.0b013e3181773d5d.

PMID:
18594400
4.

Ophthalmic Manifestations of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis and Relation to SCORTEN.

Morales ME, Purdue GF, Verity SM, Arnoldo BD, Blomquist PH.

Am J Ophthalmol. 2010 Oct;150(4):505-510.e1. doi: 10.1016/j.ajo.2010.04.026. Epub 2010 Jul 8.

PMID:
20619392
5.
6.

Mortality and use of the auxiliary score in extensive toxic epidermal necrolysis patients admitted to an adult burns referral centre.

Mahar PD, Wasiak J, Cleland H, Watters D, Paul E, Marsh P, Gin D.

Dermatology. 2013;227(2):180-5. doi: 10.1159/000354264. Epub 2013 Sep 27.

PMID:
24080507
7.

SCORTEN accurately predicts mortality among toxic epidermal necrolysis patients treated in a burn center.

Cartotto R, Mayich M, Nickerson D, Gomez M.

J Burn Care Res. 2008 Jan-Feb;29(1):141-6. doi: 10.1097/BCR.0b013e31815f3865.

PMID:
18182912
8.

[Stevens-Johnson syndrome and toxic epidermal necrolysis: a 15-year retrospective study].

Moniz P, Casal D, Mavioso C, Castro JV, Almeida MA.

Acta Med Port. 2011 Jan-Feb;24(1):59-70. Epub 2011 Feb 28. Portuguese.

9.

Early treatment with nonsucrose intravenous immunoglobulin in a burn unit reduces toxic epidermal necrolysis mortality.

Aires DJ, Fraga G, Korentager R, Richie CP, Aggarwal S, Wick J, Liu DY.

J Drugs Dermatol. 2013 Jun 1;12(6):679-84.

PMID:
23839186
10.

Outcome of patients with toxic epidermal necrolysis syndrome revisited.

Ducic I, Shalom A, Rising W, Nagamoto K, Munster AM.

Plast Reconstr Surg. 2002 Sep 1;110(3):768-73.

PMID:
12172137
11.

Prognostic value of histologic features of toxic epidermal necrolysis.

Valeyrie-Allanore L, Bastuji-Garin S, Guégan S, Ortonne N, Bagot M, Roujeau JC, Revuz JE, Wechsler J, Wolkenstein P.

J Am Acad Dermatol. 2013 Feb;68(2):e29-35. doi: 10.1016/j.jaad.2011.10.007. Epub 2011 Nov 16.

PMID:
22088428
12.

Examining triage patterns of inhalation injury and toxic epidermal necrolysis-Stevens Johnson syndrome.

Davis JS, Pandya RK, Pizano LR, Namias N, Dearwater S, Schulman CI.

J Burn Care Res. 2013 Sep-Oct;34(5):492-7. doi: 10.1097/BCR.0b013e3182a2ad17.

PMID:
23966120
13.

Characteristics of toxic epidermal necrolysis and Stevens-Johnson syndrome: a 5-year retrospective study.

Thammakumpee J, Yongsiri S.

J Med Assoc Thai. 2013 Apr;96(4):399-406.

PMID:
23691693
14.

Toxic epidermal necrolysis: five years of treatment experience from a burn unit.

Firoz BF, Henning JS, Zarzabal LA, Pollock BH.

J Am Acad Dermatol. 2012 Oct;67(4):630-5. doi: 10.1016/j.jaad.2011.12.014. Epub 2012 Jan 27. Erratum in: J Am Acad Dermatol. 2013 Dec;69(6):1048.

PMID:
22285617
15.

Pediatric toxic epidermal necrolysis: an institutional review of patients admitted to an intensive care unit.

Hamilton GM, Fish J.

J Burn Care Res. 2013 Nov-Dec;34(6):e351-8. doi: 10.1097/BCR.0b013e31827a2ac3.

PMID:
23816996
16.

Toxic epidermal necrolysis and Stevens-Johnson syndrome at the Prague Burn Centre 1998-2008.

Zajicek R, Pintar D, Broz L, Suca H, Königova R.

J Eur Acad Dermatol Venereol. 2012 May;26(5):639-43. doi: 10.1111/j.1468-3083.2011.04143.x. Epub 2011 Jun 14.

PMID:
21668825
17.

Toxic epidermal necrolysis and Stevens-Johnson syndrome: does early withdrawal of causative drugs decrease the risk of death?

Garcia-Doval I, LeCleach L, Bocquet H, Otero XL, Roujeau JC.

Arch Dermatol. 2000 Mar;136(3):323-7.

PMID:
10724193
18.

High-dose intravenous immunoglobulins in the treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis in Chinese patients: a retrospective study of 82 cases.

Chen J, Wang B, Zeng Y, Xu H.

Eur J Dermatol. 2010 Nov-Dec;20(6):743-7. doi: 10.1684/ejd.2010.1077. Epub 2010 Oct 15.

PMID:
20952352
19.
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk